Flextothink Named to 2024 Top 100 Emerging Medical Device Enterprises

To continuously leverage the radiating and driving role of national-level innovation platforms, further stimulate innovation vitality, solidly advance the high-quality development of the high-performance medical device industry, and accelerate the development of new quality productive forces in China's medical equipment sector, the National Innovation Center for High-Performance Medical Devices has organized and initiatedInsights and Assessment of the Innovative Ecosystem in the Medical Device Industry for 2024FlectoThinkSelected"Top 100 Emerging Companies in the Medical Device Industry 2024" List.

This assessment was conducted by the National Innovation Center for High-Performance Medical Devices (hereinafter referred to as"National Innovation Center") initiated, in collaboration with more than ten industrial chain ecosystem units involving "industry, academia, research, medicine, capital, policy, and management," continuing the high-standard review panel from previous sessions. Multiple senior experts and scholars from authoritative industry ecosystem institutions jointly conducted the review. After more than three months of collection, selection, preliminary review, re-review, and final review, the list eventually yielded 11 evaluation results across enterprise, individual, product, and institution categories.

Since its establishment, FlectoThinkFocus on Brain-Computer Interface Technology Research and Its Applications in Consumer Electronics and Medical Fields, has launched several leading products. Among them, the flexible electrodeEEG for brain monitoring and Metaverse-based neural 3D interaction systems is the core R&D focus of FlectoThink. These products involve various scientific fields such as flexible materials, algorithms, and AI, and also provide technical applications and services in areas like sleep monitoring, mental health screening, chronic disease rehabilitation management, and gaming within the context of internet healthcare.

FlectoThink's technological achievements in the field of sleep monitoring are particularly outstanding. The company's launched EEG monitor not only achieves a breakthrough in detection accuracy but also, through integration with the Internet of Things (IoT),IoT) devices to provide personalized sleep interventions. These products have passed the Class II medical device certification and gained widespread recognition in the market.

In addition, FlectoThink's innovative applications in the medical device field have received widespread acclaim. The company's brain-computer interface system can not only be used for medical monitoring and diagnosis but also provide effective solutions for mental health issues and chronic disease rehabilitation. Through collaborations with multiple medical and research institutions both in China and abroad, FlectoThink continues to advance the application and development of brain-computer interface technology in the healthcare sector.

FlectoThink's Successful Selection"Top 100 Emerging Companies in the 2024 Medical Device Industry Innovation Index" list not only affirms the company's innovative strength in the medical device field but also recognizes its future development potential. In the future, FlectoThink will continue to adhere to innovation-driven strategies, constantly launching more core technologies and products with independent intellectual property rights, contributing more to the development of the global medical device industry.